T1	Participants 380 458	data from two federally-funded, multi-site, randomized trials with risperidone
T2	Participants 460 524	Study 1 included 52 subjects assigned to placebo and 49 subjects
T3	Participants 571 690	Study 2 included 49 subjects assigned to risperidone only and 75 subjects assigned to risperidone plus parent training.
T4	Participants 35 59	autism spectrum disorder
